Overview

Since 1971, FDA and DEA have regulated the manufacture, importation, possession, use, and distribution of particular substances under the Controlled Substances Act. These agencies work in concert on protocols, recommendations, and information-sharing relating to schedules I through V substances. Currently, FDA and DEA’s joint initiatives seek to ensure product safety while balancing patient access through controlled substances and prescription monitoring programs. Panelists will examine the jurisdictional overlap between these agencies and impacts on the supply chain. Speakers will also discuss joint-agency efforts to combat the escalating opioid public health emergency, drug contamination issues and proposed rules for permanent telemedicine flexibilities to mitigate overprescribing and drug abuses.

Speakers

Bethany J. Hills, Partner, DLA Piper
Niketa G. Prince, Staff Coordinator (DI), DEA HQ Policy and Liaison Section, Diversion Control Division, DEA

Register

Member Price
$149		 Non-Member Price
$249		 Student Member Price
$29

 

 

Register Now

 

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.

 

An access link will be provided to attendees via email upon registration.

If you are registering on behalf of someone else, the link to access the webinar will go to the email address provided at the point of registration.

Those registering on the day of the webinar will receive an access link via email upon successful payment.

 

We use Zoom to conduct webinars which works on most devices. You may participate in the webinar on a mobile device via the Zoom App or by dialing in. If you require the dial in information, please contact Maura Schatz at [email protected].

Test your device: https://support.zoom.us/hc/en-us/articles/201362193-Joining-a-meeting

 

Webinar recordings are sent via email as soon as we are able to process and verify the quality of the recording. This usually occurs within 3 business days of a webinar broadcast.

If multiple people at your organization wish to participate from separate devices, each will be required to purchase access.